TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership590,047 shares
Latest Disclosed Value $ 19,601,362
D. E. Shaw & Co., Inc. ownership in 1TGTX / TG Therapeutics, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 590,047 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $16,320,700 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 700,345 shares of TG Therapeutics, Inc.. This represents a change in shares of -15.75% during the quarter. The current value of the position is $20,061,598 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (1TGTX) in the form of stock options. The firm currently holds call options representing 15,200 of underlying shares valued at $504,944 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1TGTX / TG Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 590,047 -110,298 -15.75 19,601 -6.11 0.0087
2026-02-17 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 700,345 468,322 201.84 20,877 149.10 0.0114
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 232,023 113,886 96.40 8,382 97.15 0.0047
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 118,137 56,207 90.76 4,252 74.15 0.0030
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 61,930 -106,573 -63.25 2,442 -51.86 0.0022
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 168,503 -226,276 -57.32 5,072 -45.08 0.0037
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 394,779 154,767 64.48 9,234 116.28 0.0079
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 240,012 150,410 167.86 4,270 213.44 0.0040
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 89,602 -173,176 -65.90 1,363 -69.65 0.0012
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 262,778 127,581 94.37 4,488 297.17 0.0039
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 135,197 -1,440,274 -91.42 1,130 -97.11 0.0012
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 1,575,471 741,694 88.96 39,135 212.07 0.0400
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 833,777 -1,370,453 -62.17 12,540 -51.91 0.0134
2023-02-14 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 2,204,230 1,503,230 214.44 26,076 528.34 0.0288
2022-11-14 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 701,000 -512,778 -42.25 4,150 -19.56 0.0050
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 1,213,778 943,427 348.96 5,159 100.66 0.0060
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 270,351 253,317 1,487.13 2,571 693.52 0.0024
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 17,034 -2,404 -12.37 324 -49.92 0.0003
2021-11-15 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 19,438 -138,142 -87.66 647 -89.42 0.0006
2021-08-16 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 157,580 -377,421 -70.55 6,113 -76.29 0.0053
2021-05-17 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 535,001 -333,478 -38.40 25,787 -42.92 0.0249
2021-02-16 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 868,479 344,892 65.87 45,178 222.45 0.0404
2020-11-16 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 523,587 263,544 101.35 14,011 176.57 0.0143
2020-08-14 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 260,043 -21,850 -7.75 5,066 82.62 0.0060
2020-05-15 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 281,893 -604,195 -68.19 2,774 -71.80 0.0043
2020-02-14 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 886,088 707,522 396.22 9,836 881.64 0.0112
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 178,566 90,697 103.22 1,002 31.84 0.0012
2019-08-14 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 87,869 -185,698 -67.88 760 -65.44 0.0009
2019-05-15 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 273,567 200,553 274.68 2,199 633.00 0.0028
2019-02-14 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 73,014 58,573 405.60 300 270.37 0.0004
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 14,441 -243,133 -94.39 81 -97.61 0.0001
2018-08-14 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 257,574 62,050 31.74 3,387 22.01 0.0044
2018-05-15 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 195,524 107,253 121.50 2,776 283.43 0.0038
2018-02-14 2017-12-31 13F TG THERAPEUTICS COM 88322Q108 88,271 -51,085 -36.66 724 -56.15 0.0010
2017-11-14 2017-09-30 13F TG THERAPEUTICS COM 88322Q108 139,356 78,019 127.20 1,651 168.02 0.0025
2017-08-14 2017-06-30 13F TG THERAPEUTICS COM 88322Q108 61,337 15,624 34.18 616 15.57 0.0010
2017-05-15 2017-03-31 13F TG THERAPEUTICS COM 88322Q108 45,713 45,713 533 0.0009
2015-11-16 2015-09-30 13F TG THERAPEUTICS COM 88322Q108 0 -81,342 -100.00 0 -100.00
2015-08-14 2015-06-30 13F TG THERAPEUTICS COM 88322Q108 81,342 19,996 32.60 1,349 42.00 0.0020
2015-05-15 2015-03-31 13F TG THERAPEUTICS COM 88322Q108 61,346 61,346 950 0.0015
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TG THERAPEUTICS COM Call 15,200 -77.68 505 -75.17 n/a n/a n/a
2026-02-17 2025-12-31 13F TG THERAPEUTICS COM Call 68,100 -20.63 2,030 -34.49 n/a n/a n/a
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM Call 85,800 -20.04 3,100 -19.74 n/a n/a n/a
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM Call 107,300 71.68 3,862 56.70 n/a n/a n/a
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM Call 62,500 11.81 2,464 46.49 n/a n/a n/a
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM Call 55,900 1,683 n/a n/a n/a
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM Call 18,400 327 n/a n/a n/a
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM Call 11,200 0.00 191 105.38 n/a n/a n/a
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM Call 11,200 0.00 94 -66.55 n/a n/a n/a
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM Call 11,200 278 n/a n/a n/a
2020-11-16 2020-09-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F TG THERAPEUTICS COM Call 50,000 974 n/a n/a n/a
2018-08-14 2018-06-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F TG THERAPEUTICS COM Call 21,900 311 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.